These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 32373124)
1. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A Front Immunol; 2020; 11():664. PubMed ID: 32373124 [TBL] [Abstract][Full Text] [Related]
2. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis. Altınönder İ; Kaya M; Yentür SP; Çakar A; Durmuş H; Yegen G; Özkan B; Parman Y; Sawalha AH; Saruhan-Direskeneli G J Neuroinflammation; 2024 May; 21(1):126. PubMed ID: 38734662 [TBL] [Abstract][Full Text] [Related]
3. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells. Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506 [TBL] [Abstract][Full Text] [Related]
4. [Expression of CD20 in thymomas and its clinical implication]. Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589 [TBL] [Abstract][Full Text] [Related]
5. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis. Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484 [TBL] [Abstract][Full Text] [Related]
6. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864 [TBL] [Abstract][Full Text] [Related]
7. Integrated proteomics and metabolomics analysis reveals hubs protein and network alterations in myasthenia gravis. Tong T; Zhang J; Jia L; Liang P; Wang N Aging (Albany NY); 2022 Jul; 14(13):5417-5426. PubMed ID: 35802752 [TBL] [Abstract][Full Text] [Related]
8. Genetic characterization of thymoma. Yu L; Ke J; Du X; Yu Z; Gao D Sci Rep; 2019 Feb; 9(1):2369. PubMed ID: 30787364 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological aspects of thymic epithelial tumors. Okumura M; Shiono H; Minami M; Inoue M; Utsumi T; Kadota Y; Sawa Y Gen Thorac Cardiovasc Surg; 2008 Jan; 56(1):10-6. PubMed ID: 18213465 [TBL] [Abstract][Full Text] [Related]
11. Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis. Coppedè F; Stoccoro A; Nicolì V; Gallo R; De Rosa A; Guida M; Maestri M; Lucchi M; Ricciardi R; Migliore L Gene; 2020 Aug; 752():144774. PubMed ID: 32442579 [TBL] [Abstract][Full Text] [Related]
12. cFLIP overexpression in T cells in thymoma-associated myasthenia gravis. Belharazem D; Schalke B; Gold R; Nix W; Vitacolonna M; Hohenberger P; Roessner E; Schulze TJ; Saruhan-Direskeneli G; Yilmaz V; Ott G; Ströbel P; Marx A Ann Clin Transl Neurol; 2015 Sep; 2(9):894-905. PubMed ID: 26401511 [TBL] [Abstract][Full Text] [Related]
13. Thymoma related myasthenia gravis in humans and potential animal models. Marx A; Porubsky S; Belharazem D; Saruhan-Direskeneli G; Schalke B; Ströbel P; Weis CA Exp Neurol; 2015 Aug; 270():55-65. PubMed ID: 25700911 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells. Li J; Qiu D; Chen Z; Du W; Liu J; Mo X Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774 [TBL] [Abstract][Full Text] [Related]
15. Role of miRNAs in Normal and Myasthenia Gravis Thymus. Cron MA; Guillochon É; Kusner L; Le Panse R Front Immunol; 2020; 11():1074. PubMed ID: 32587589 [TBL] [Abstract][Full Text] [Related]
16. Pathological aspects of malignant and benign thymic disorders. Müller-Hermelink HK; Marx A Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149 [TBL] [Abstract][Full Text] [Related]
17. Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis. Wilisch A; Gutsche S; Hoffacker V; Schultz A; Tzartos S; Nix W; Schalke B; Schneider C; Müller-Hermelink HK; Marx A Neurology; 1999 Apr; 52(7):1460-6. PubMed ID: 10227635 [TBL] [Abstract][Full Text] [Related]
18. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765 [TBL] [Abstract][Full Text] [Related]
19. Invasive medullary thymoma associated with Myasthenia gravis: an unusual case. Reis Filho JS; Milanezi MF; Moreira CG; Werneck LC; Boscardin P; Ioshii SO; Schmitt FC Arq Neuropsiquiatr; 2000 Dec; 58(4):1110-4. PubMed ID: 11105080 [TBL] [Abstract][Full Text] [Related]
20. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Inoue M; Starostik P; Zettl A; Ströbel P; Schwarz S; Scaravilli F; Henry K; Willcox N; Müller-Hermelink HK; Marx A Cancer Res; 2003 Jul; 63(13):3708-15. PubMed ID: 12839963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]